MedTrace Logo

Myocardial Injury After Elective Coronary Stenting

NCT01986621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2018-05-30

No results posted yet for this study

Summary

This pilot study aims to identify patients at moderate to high risk for peri-procedural (type 4) myocardial infarction or injury after after undergoing an elective coronary intervention (PCI) as measured by high sensitivity troponin T, who might benefit from more potent antiplatelet therapy.

Conditions

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Haitham Abu Sharar, Dr. med. · University Hospital Heidelberg

  • Evangelos Giannitsis, Prof. Dr. · University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-03-31
Completion
2015-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01986621 on ClinicalTrials.gov